Latest Cost Reduction Initiatives News

Experience Co Limited reports a modest half-year revenue increase despite challenges in Q2, driven by strong Reef Unlimited and Skydive New Zealand performances offsetting softness elsewhere.

Microba Life Sciences reports a 90% year-on-year increase in core microbiome test volumes, driving a 123% rise in core testing revenue to $2.1 million, while advancing clinical adoption and cost efficiencies.

Brazilian Critical Minerals has reported significant progress at its Ema rare earths project, producing a high-grade rare earth carbonate rich in critical magnet metals and advancing key drilling, permitting, and feasibility milestones.

Coventry Group reports a solid half-year sales and earnings improvement while initiating a strategic review following unsolicited takeover interest.

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

Fenix Resources unveils a robust three-year plan to ramp up iron ore production from 2.4Mt in FY25 to 6Mtpa by FY28, anchored by its Weld Range Project. The company also raises FY26 guidance and initiates feasibility studies for further expansion.

Metroglass has reported a 5% revenue decline in its half-year results but achieved a significant reduction in net debt and improved profitability, signaling progress in its turnaround strategy amid challenging market conditions.

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million for FY25, alongside an 8.1% decline in underlying NPAT, aligning with prior guidance. The company outlined a cautious FY26 outlook focused on innovation, doctor retention, and cost management.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Iress launches a comprehensive FY26 business efficiency program targeting a 25% cash EBITDA margin, while narrowing its FY25 guidance and welcoming a new CEO.

Woodside Energy Group unveiled an ambitious growth strategy at its 2025 Capital Markets Day, targeting a net operating cash flow of around US$9 billion by the early 2030s, driven by key LNG and ammonia projects.